DEXCOM INC - Common Stock (DXCM) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
DXCM on Nasdaq
Shares outstanding
392,193,323
Price per share
$72.86
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
360,259,812
Total reported value
$23,914,563,432
% of total 13F portfolios
0.01%
Share change
+1,622,032
Value change
+$95,828,298
Number of holders
897
Price from insider filings
$72.86
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of DEXCOM INC - Common Stock (DXCM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 13% $3,327,865,844 49,455,578 The Vanguard Group 30 Sep 2025
BlackRock, Inc. 8.3% $2,317,545,182 32,504,140 BlackRock, Inc. 31 Mar 2025

As of 31 Dec 2025, 897 institutional investors reported holding 360,259,812 shares of DEXCOM INC - Common Stock (DXCM). This represents 92% of the company’s total 392,193,323 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of DEXCOM INC - Common Stock (DXCM) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 13% 49,074,378 -0.77% 0.05% $3,257,066,468
BlackRock, Inc. 10% 39,848,377 +2.6% 0.04% $2,644,736,811
STATE STREET CORP 4.6% 18,093,554 +7.3% 0.04% $1,200,869,179
BAILLIE GIFFORD & CO 4% 15,552,587 -2.1% 0.86% $1,032,225,198
GEODE CAPITAL MANAGEMENT, LLC 2.8% 11,006,183 +0.39% 0.04% $727,841,809
ALLIANCEBERNSTEIN L.P. 2.2% 8,624,132 +1955% 0.18% $572,383,641
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 2% 7,999,057 +6.9% 0.11% $530,897,413
NORGES BANK 1.9% 7,282,743 0.05% $483,355,653
JPMORGAN CHASE & CO 1.6% 6,216,401 +0.04% 0.03% $412,582,596
JENNISON ASSOCIATES LLC 1.5% 5,789,944 -43% 0.23% $384,278,588
Invesco Ltd. 1.4% 5,315,367 +15% 0.05% $352,780,915
MORGAN STANLEY 1.3% 5,072,646 +17% 0.02% $336,671,733
Amundi 1.3% 4,917,921 -2% 0.1% $326,402,417
Nuveen, LLC 1.2% 4,632,271 -27% 0.08% $307,443,825
DEUTSCHE BANK AG\ 1.1% 4,329,213 +52% 0.09% $287,329,869
D. E. Shaw & Co., Inc. 1% 3,938,568 +79% 0.2% $261,402,758
BANK OF AMERICA CORP /DE/ 0.97% 3,813,212 -12% 0.02% $253,082,872
NORTHERN TRUST CORP 0.86% 3,376,421 -9.3% 0.03% $224,093,062
CIBC Private Wealth Group LLC 0.8% 3,128,114 +7.6% 0.35% $207,612,942
AQR CAPITAL MANAGEMENT LLC 0.79% 3,102,789 +598% 0.11% $205,932,104
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.79% 3,079,311 -3.3% 0.03% $204,373,871
WELLINGTON MANAGEMENT GROUP LLP 0.78% 3,073,575 +3777% 0.04% $203,993,172
FRANKLIN RESOURCES INC 0.68% 2,682,761 +9.7% 0.04% $178,054,847
Legal & General Group Plc 0.66% 2,605,282 -1.2% 0.04% $172,912,568
ROYAL BANK OF CANADA 0.65% 2,539,748 -20% 0.03% $168,563,000

Institutional Holders of DEXCOM INC - Common Stock (DXCM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 360,259,812 $23,914,563,432 +$95,828,298 $66.37 897
2025 Q3 362,173,493 $24,358,855,958 -$446,610,980 $67.29 896
2025 Q2 363,717,079 $31,720,153,850 +$620,498,372 $87.29 929
2025 Q1 357,522,884 $24,367,959,079 -$21,830,100 $68.29 918
2024 Q4 356,520,250 $27,741,592,016 -$279,743,784 $77.77 940
2024 Q3 357,200,222 $23,960,310,643 -$1,530,910,004 $67.04 871
2024 Q2 373,073,419 $42,285,500,029 +$662,526,670 $113.38 980
2024 Q1 367,433,762 $50,918,835,024 -$893,108,760 $138.70 1,023
2023 Q4 376,420,513 $46,714,761,535 +$1,256,458,516 $124.09 963
2023 Q3 367,596,728 $34,254,428,099 -$325,172,905 $93.30 890
2023 Q2 368,588,625 $47,303,203,662 -$86,323,559 $128.51 940
2023 Q1 369,281,709 $42,884,123,591 +$52,677,258 $116.18 891
2022 Q4 373,099,760 $42,233,817,121 +$225,153,200 $113.24 901
2022 Q3 371,208,363 $29,922,677,791 -$111,395,992 $80.54 760
2022 Q2 370,318,253 $27,605,947,295 +$20,054,274,905 $74.53 772
2022 Q1 94,624,602 $48,293,370,260 +$1,138,375,535 $511.60 843
2021 Q4 92,168,299 $49,456,533,397 -$1,108,963,197 $536.95 906
2021 Q3 93,700,793 $51,237,135,830 -$502,542,871 $546.86 784
2021 Q2 94,700,933 $40,431,864,257 +$1,510,178,055 $427.00 716
2021 Q1 92,085,325 $33,095,119,084 +$509,060,434 $359.39 716
2020 Q4 90,898,678 $33,599,827,733 -$501,643,933 $369.72 716
2020 Q3 91,873,135 $37,818,156,552 -$149,409,008 $412.23 717
2020 Q2 92,133,123 $37,347,784,993 +$419,792,629 $405.40 709
2020 Q1 91,229,803 $24,563,570,490 +$161,888,036 $269.27 572
2019 Q4 90,965,759 $19,892,612,814 +$32,992,514 $218.74 495
2019 Q3 90,939,617 $13,568,950,213 +$328,190,271 $149.24 413
2019 Q2 88,725,626 $13,273,745,103 +$356,759,485 $149.84 410
2019 Q1 88,583,997 $10,548,018,596 +$38,787,031 $119.10 446
2018 Q4 88,184,599 $10,564,179,360 -$129,808,671 $119.80 407
2018 Q3 88,760,661 $12,695,745,879 -$611,032,557 $143.04 360
2018 Q2 93,215,950 $8,853,465,121 -$922,123,660 $94.98 280
2018 Q1 103,355,148 $7,664,869,633 +$5,330,131 $74.16 267
2017 Q4 102,947,641 $5,908,051,029 +$82,535,646 $57.39 267
2017 Q3 101,797,384 $4,971,892,668 +$151,443,618 $48.92 269
2017 Q2 97,682,211 $7,143,294,052 +$675,762,206 $73.15 305
2017 Q1 91,924,314 $7,784,141,995 +$246,630,175 $84.73 314
2016 Q4 93,369,609 $5,574,692,280 +$200,388,424 $59.70 302
2016 Q3 89,469,214 $7,840,742,412 +$510,941,803 $87.66 283
2016 Q2 83,960,314 $6,659,461,084 +$465,790,843 $79.33 268
2016 Q1 78,724,266 $5,345,859,492 +$152,413,063 $67.91 258
2015 Q4 75,548,378 $6,187,429,650 +$150,114,111 $81.90 281
2015 Q3 73,614,783 $6,320,383,982 +$12,932,607 $85.86 276
2015 Q2 74,093,790 $5,926,046,438 +$109,671,235 $79.98 256
2015 Q1 72,843,288 $4,540,967,355 +$30,872,775 $62.34 241
2014 Q4 72,420,537 $3,988,379,352 -$127,403,087 $55.05 226
2014 Q3 74,202,000 $2,967,701,226 +$83,399,713 $39.99 199
2014 Q2 72,079,159 $2,858,047,986 +$96,346,179 $39.66 189
2014 Q1 69,248,060 $2,863,172,240 +$10,785,157 $41.36 209